057680 — T Scientific Co Income Statement
0.000.00%
- KR₩62bn
- KR₩66bn
- KR₩43bn
Annual income statement for T Scientific Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,519 | 10,084 | 8,694 | 26,769 | 43,017 |
Cost of Revenue | |||||
Gross Profit | 3,753 | 4,253 | 4,187 | 8,121 | 9,954 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,794 | 9,082 | 11,183 | 59,127 | 51,982 |
Operating Profit | 725 | 1,002 | -2,488 | -32,357 | -8,965 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -683 | -2,959 | -15,890 | -54,262 | 1,308 |
Provision for Income Taxes | |||||
Net Income After Taxes | 652 | -3,162 | -11,808 | -48,737 | 2,289 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 652 | -3,162 | -11,110 | -45,414 | 2,223 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 652 | -3,162 | -11,110 | -45,414 | 2,223 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 14.7 | -67.6 | -209 | -455 | 25.3 |
Dividends per Share |